Home » Topics » BioWorld Science

BioWorld Science
RSS

AIkido to use machine learning in development of novel broad-spectrum antivirals

Aug. 9, 2021

Targeting synaptogyrin-3 can ameliorate cognitive deficits

Aug. 9, 2021

Ichnos nominates ISB-1442 as its next clinical candidate

Aug. 9, 2021

ImmVira receives NMPA approval for clinical testing of intravenous MVR-T3011

Aug. 9, 2021

New SHP-2 inhibitors identified at Beijing Innocare Pharmaceutical Technology

Aug. 9, 2021

Dongguan Hec New Drug Research and Development, Sunshine Lake Pharma identify HBV inhibitors

Aug. 9, 2021

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent PROTACs targeting cereblon

Aug. 9, 2021

Heparegenix identifies new MAPKK 4 inhibitors

Aug. 9, 2021

Discovery and preclinical characterization of a novel anti-SARS-CoV-2 MAb, MW-06

Aug. 9, 2021

Enrollment ongoing in first-in-human study of [68Ga]-FF58

Aug. 6, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...